| NCT ID | NCT07166471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Perspectum |
| Condition | Healthy Participants |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-01-01 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to undertake the Global Reference Range Study (GRR) to establish a set of healthy adult reference values for measures of fibroinflammation, fat and size/volumes for the liver, and other abdominal and thoracic organs to assess, compare, and if necessary, propose ethnicity specific reference ranges for these measurements.
Eligibility Criteria
Inclusion Criteria: * Male or female at least 18 years of age * Self-reported healthy * Willing and able to give informed consent for participation in the study * Willing and able to undergo an MRI Exclusion Criteria: * History of cardiovascular disease as follows: * Myocardial infarction * Heart failure * Cardiomyopathy * Stroke * Hospital admission/discharge for unstable angina * Heart surgery * Unstable angina * Transient ischemic attack * Presence of CVD risk factors such as hypertension, hyperlipidaemia, Type 2 diabetes, BMI \> 30 kg/m2, smoker (current/ex-smoker) * History of non-cardiac diseases related to the lungs, liver, kidneys, pancreas or spleen judged by the study investigator as therefore unsuitable to participate in the study * The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MRI exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia) * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study
Contact & Investigator
Ravi Pattanshetty
STUDY CHAIR
Perspectum
Frequently Asked Questions
Who can join the NCT07166471 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07166471 currently recruiting?
Yes, NCT07166471 is actively recruiting participants. Contact the research team at masliza.mahmod@perspectum.com for enrollment information.
Where is the NCT07166471 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07166471 clinical trial?
NCT07166471 is sponsored by Perspectum. The principal investigator is Ravi Pattanshetty at Perspectum. The trial plans to enroll 50 participants.